Eve Energy Announces Plan to Reduce Stake in Smoore by No More than 3.5%

Business by 2FIRSTS.ai
Jun.28.2024
Eve Energy Announces Plan to Reduce Stake in Smoore by No More than 3.5%
Eve Energy plans to reduce stake in Smoore International by 3.5% through bulk trading within a year.

On the evening of June 27th, Eve Energy (stock code 300014) issued a notice regarding the expiration of the plan to reduce holdings of shares in the invested company and the subsequent plan to reduce holdings. The announcement authorized the company's chairman to reduce, at his discretion, up to 3.5% of the shares held by the wholly-owned subsidiary EVE BATTERY INVESTMENT LTD in Smoore International Holdings Limited through bulk trading within one year from the date of approval by the board of directors.

 

Eve Energy has announced that as of the date of this announcement, the previous divestment plan has expired and the company has not reduced its holdings of Smoore International stock held by EBIL.

 

In the announcement made by Eve Energy, the company's wholly-owned subsidiary EBIL holds 1,901,520,000 shares of Smoore International, representing approximately 30.98% of the total issued shares of Smoore International.

 

In order to enhance the company's dynamic market value management, fully utilize existing resources, maximize the company's economic benefits, and further increase investment in research and development platforms, the company plans to seek authorization from the board of directors for the chairman to, within one year from the date of board approval, strategically reduce EBIL's holding of no more than 3.5% (approximately 214.8195 million shares) of Smoore International stock through block trades.

 

According to the announcement from Eve Energy, the reduction of shares has been approved by the 35th meeting of the sixth board of directors in accordance with the rules of the Shenzhen Stock Exchange's Growth Enterprise Board Listing Rules and the company's articles of association. It does not need to be approved by the company's shareholders meeting.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

FDA Appoints Bret Koplow as Acting Director of CTP
FDA Appoints Bret Koplow as Acting Director of CTP
According to the U.S. Food and Drug Administration’s website, Bret Koplow has been appointed acting director of the Center for Tobacco Products (CTP). Koplow has been with the FDA since 2011, holding several key roles, most recently serving as senior advisor to the FDA Commissioner.
May.21 by 2FIRSTS.ai
JTI Plans to Produce Ploom X in the US
JTI Plans to Produce Ploom X in the US
JTI plans to produce Ploom X in the US due to Trump's tariff policies and supply chain trends, aiming for FDA approval.
May.28 by 2FIRSTS.ai
PMI Launches IQOS ILUMA i In Bulgaria Market
PMI Launches IQOS ILUMA i In Bulgaria Market
Philip Morris International' s Bulgaria branch has launched the "IQOS ILUMA I" heated tobacco device, featuring three models equipped with touchscreens and customizable settings. The company now has over 450,000 IQOS users in Bulgaria.
Apr.25 by 2FIRSTS.ai
27,000 illegal e-cigarettes seized by UK trade standards council.
27,000 illegal e-cigarettes seized by UK trade standards council.
Sheffield City Council has confiscated 27,000 illegal e-cigarettes from a warehouse and seized nearly 12,000 from retailers over the past year. Three businesses have been fined for selling e-cigarettes to minors. Local officials are urging for stronger regulations to prevent high-nicotine products from attracting young people to use them.
Apr.27 by 2FIRSTS.ai
Estonia Bans Flavored Heated Tobacco Sales from Feb 2026 Under New Law
Estonia Bans Flavored Heated Tobacco Sales from Feb 2026 Under New Law
Estonia’s parliament has passed an amendment to the Tobacco Act, banning the sale of flavored and scented heated tobacco products starting January 31, 2026. The revision sets rules on product composition, labeling, and penalties for violations. Manufacturers must submit product information to health authorities before market entry.
Apr.24 by 2FIRSTS.ai
Ispire Appoints Jie "Jay" Yu As New CFO
Ispire Appoints Jie "Jay" Yu As New CFO
Ispire Technology Inc. has appointed Jie "Jay" Yu as its new Chief Financial Officer, replacing Jim McCormick. As part of ongoing efforts to streamline operations, the company expects to cut $3.6 million in payroll costs by May 2025 and up to $6.6 million more in operating expenses over the next three months, targeting a total annualized savings of $10.2 million.
May.16 by 2FIRSTS.ai